Home » Stocks » CBPO

China Biologic Products Holdings, Inc. (CBPO)

Apr 21, 2021 - CBPO was delisted (reason: taken private)
Stock Price: $119.99 USD 1.98 (1.68%)
Updated Apr 20, 2021 4:00 PM EDT
Market Cap 4.55B
Revenue (ttm) 524.37M
Net Income (ttm) 152.29M
Shares Out 38.58M
EPS (ttm) 3.82
PE Ratio 31.41
Forward PE 22.32
Dividend n/a
Dividend Yield n/a
Trading Day Jun 21, 2021
Last Price $119.99
Previous Close $118.01
Change ($) 1.98
Change (%) 1.68%
Day's Open 118.01
Day's Range 117.27 - 120.09
Day's Volume 390,921
52-Week Range 99.74 - 120.09

News

Hide News

BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in Chi...

2 months ago - PRNewsWire

BEIJING, March 29, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in Chi...

2 months ago - PRNewsWire

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

BEIJING, Nov. 13, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in Chi...

7 months ago - PRNewsWire

It's a good time to separate the weak from the strong. The post 7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio appeared first on InvestorPlace.

Other stocks mentioned: GLPG, HRTX, ILMN, IONS, RGNX, LGND
7 months ago - InvestorPlace

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

The following companies have grown their earnings per share over a five-year period.

Other stocks mentioned: BIIB, GRFS, HCA, UHS
11 months ago - GuruFocus

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

These stocks slot into any portfolio and will pack a special punch.

Other stocks mentioned: AVP, CG, KGC, MANT, VIPS, WTR
1 year ago - InvestorPlace

Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.

Other stocks mentioned: ACAD, ARWR, GLPG, NTRA, ONCE, ZLAB
1 year ago - InvestorPlace

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

As of September 18, 2019, the company received a non-binding proposal to be acquired for $120/share.

1 year ago - Seeking Alpha

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

According to the GuruFocus All-In-One Screener, the following companies have grown their book value per share over the past decade.

Other stocks mentioned: BFR, DFS, MGA, UHAL
1 year ago - GuruFocus

China Biologic Products Holdings, Inc. (CBPO) Management on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

China Biologic Products (CBPO) delivered earnings and revenue surprises of 12.12% and 8.61%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

2 years ago - Zacks Investment Research

China Biologic Products (CBPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

China Biologic Products (CBPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

The fastest growing fast-casual franchise as restaurant spending surges

YouTube video

Jersey Mike's CEO Peter Cancro discusses his company's expansion as restaurant spending in the U.S. has surged in the last three months, to the most on record.

Other stocks mentioned: SBUX, STI
2 years ago - CNBC Television

About CBPO

China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also... [Read more...]

Industry
Biotechnology
CEO
Joseph Chow
Country
China
Stock Exchange
NASDAQ
Ticker Symbol
CBPO
Full Company Profile

Financial Performance

In 2020, CBPO's revenue was $524.37 million, an increase of 4.09% compared to the previous year's $503.74 million. Earnings were $152.29 million, an increase of 9.71%.

Financial Statements